PubMed Health⌕ Search

Biomedical subjects

W B Hughes

Publications and source records attributed to W B Hughes.

5 recordsLinked to original sources
PubMed1977

Multiple primary cancers: relative risk in New Mexico's triethnic population.

A review of the population-based New Mexico Tumor Registry data identified 446 patients with nonsimultaneous multiple primary cancers, excluding non-melanoma skin cancers and carcinomas in situ of the uterine cervix. Expected numbers of cases were established by observing the person-years of exposure to the risk of developing a second or subsequent primary cancer and then applying the appropriate locally determined age-, sex-, ethnic-, and site-specific cancer incidence rates. The relative risk (observed/expected) of developing a second primary cancer was elevated for "Anglo" and Spanish American cancer patients in comparison with the risk of developing a first primary cancer in persons who have never had one. Only six cases of nonsimultaneous multiple primary cancer were observed (6.39 expected) in the region's American Indian population. There were differences in site-site associations among the three ethnic groups, but in many categories there were too few cases for analysis.

Ethnicity↗
PubMedDate not supplied

Intradermal injection of epinephrine to decrease blood loss during split-thickness skin grafting.

After a burn injury, the hemodynamics of a patient is changed. There is usually a fall in hematocrit. In addition to this, there is the loss of blood during the grafting procedure. Some patients cannot tolerate this loss of blood. The method we use to help decrease the loss of blood during skin grafting is an injection of epinephrine intradermally before the graft and eschar are excised. We have found this method to be useful in a select group of patients.

Adult↗
PubMedDate not supplied

The 1998 Moyer Award. Characteristics of thrombospondin-1 and its cysteine-serine-valine-threonine-cysteine-glycine receptor in burn wounds.

Thrombospondin-1 (TSP-1), an adhesive glycoprotein, plays an important role in platelet adhesion, inflammation, cell-to-cell interaction, and angiogenesis. TSP-1 is expressed by endothelial cells, fibroblasts, and macrophages. TSP-1's unique cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) specific receptor plays an important role in the binding and modulation of cellular adhesion and invasion. This article histologically and quantitatively evaluates TSP-1 and its CSVTCG receptor in adult burn wounds over time. Tissue was obtained from burn wounds on several days and samples that were 5 microns thick were placed on slides. Expression of TSP-1 and its CSVTCG receptor were evaluated immunohistochemically and quantitated by computer image analysis in units of absorbance. Immunoglobin G (IgG) (negative) controls were performed and subtracted from the TSP-1 sample to eliminate background absorbance readings. Serum (negative) control was used for the CSVTCG receptor. Platelet concentrates were used as the positive control. A quantitative examination of the results yielded the following information, expressed as absorbance +/- standard error of the mean: TSP-1: day 1, 62.0 +/- 10.13; day 3, 76.2 +/- 6.90; day 5, 36.0 +/- 3.96; day 7, 60.4 +/- 5.67; and day 9, 29.5 +/- 2.91. TSP-1 displays an early peak, followed by a steep decrease over the time period studied. The readings for the CSVTCG receptor are as follows: day 1, 33.8 +/- 1.87; day 3, 34.5 +/- 5.39; day 7, 39.1 +/- 1.93; day 21, 39.1 +/- 1.93; day 28, 34.8 +/- 3.67. In contrast, the CVSTCG receptor continues to be present in the wound over time. Histologic findings are reported, and photographs and a histopathologic analysis are included. The information presented in this article leads to the conclusion that temporal and histologic differences exist in the localization and expression of TSP-1 and its CSVTCG receptor. TSP-1 is up-regulated in injured tissues immediately after the injury; it is rapidly down-regulated as the tissue heals. In contrast, the levels of the CSVTCG receptor remain relatively constant during the healing process. These data are consistent with TSP-1's known role in cell-to-cell interaction, including the modulation of the growth factor and protease activity.

Adult↗